Brief: There will be 15% U.S. tariffs on pharma, exemption for rare diseases, Recordati CEO says
July 30 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA RECI.MI CEO Robert Koremans says in post-results conference call: ITALY'S RECORDATI CEO: FROM WHAT WE HEAR THERE WILL BE 15% US TARIFF ON PHARMA PRODUCTS, RARE DISEASES ARE EXCLUDED Further company coverage: RECI.MI (Reporting by Milan Newsroom) ((cristina.carlevaro@thomsonreuters.com; +39 02 66129585;))
Recent news on Recordati Industria Chimica e Farmaceutica
See all newsItaly - Factors to watch on October 26
Deals of the day-Mergers and acquisitions
Brief: Recordati Says 66.67% Threshold Condition In Recordati Fulfilled
Brief: Recordati - CVC Capital Partners IX Aggregator Holds 19,189,219 Recordati Shares, 9.18% Of Share Capital
CVC, GBL hold 74.3% of Italian drugmaker Recordati at end of takeover offer period